Acurx Pharmaceuticals, Inc. (ACXP) stock
Close on Nov 13, 2026Market cap $5.06MP/E –Yield –
Acurx Pharmaceuticals statistics
56 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.69
- 2.22
Share statisticsIndustry
- Shares Change (YoY)
- 210.0%
- 10.8%
- Shares Change (QoQ)
- 25.5%
- 0.50%
- Float
- 3M
- 49M
- Shares Held by Insiders
- 48.8%
- 11.7%
- Shares Held by Institutions
- 2.36%
- 56.4%
Short sellingIndustry
- Short Interest
- 97,568
- –
- Short Interest Change
- 7.47%
- -0.80%
- Short % of Float
- 3.62%
- 9.01%
- Short % of Shares Outstanding
- 1.85%
- 6.30%
- Days to Cover
- 1.63
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $7.54
- –
- 52-Week Low
- $0.92
- –
- 20-Day Moving Average
- $1.06
- –
- 50-Day Moving Average
- $1.22
- –
- 200-Day Moving Average
- $1.89
- –
- Average True Range (14)
- $0.08
- –
- Price Change (1 Week)
- -9.43%
- -1.15%
- Price Change (1 Month)
- -17.9%
- -4.87%
- Price Change (3 Months)
- -41.8%
- -21.0%
- Price Change (6 Months)
- -50.0%
- -20.6%
- Price Change (YTD)
- -61.4%
- -23.6%
- Price Change (1 Year)
- -80.7%
- -22.4%
- Price Change (3 Years)
- -98.6%
- -29.5%
- Price Change (5 Years)
- -99.0%
- -77.9%
- Average Volume (10 Days)
- 150,236
- –
- Average Volume (20 Days)
- 100,156
- –
- Average Volume (90 Days)
- 117,836
- –
- Relative Volume
- 1.92
- 0.70
- Relative Strength Index (14)
- 32.9
- 43.4
- Volatility (1 Year)
- 161.0%
- 80.1%
- Beta (5 Years)
- -0.09
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -147.5%
- -49.9%
- Return on Assets (ROA)
- -98.5%
- -40.6%
- Return on Capital Employed (ROCE)
- -112.6%
- -37.9%
Financial positionIndustry
- Quick Ratio
- 3.23
- 2.39
EfficiencyIndustry
- Profits Per Employee
- -$2.02M
- -$689.41K
- Employee Count
- 4
- 74
- WACC
- 7.60%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $9.65M
- $17.76M
- Net Cash Per Share
- $1.83
- $0.80
- Equity (Book Value)
- $7.34M
- $53.89M
- Book Value Per Share
- $1.39
- $1.50
- Tangible Book Value
- $7.34M
- $27.13M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -160.0%
- -21.8%
Scores and fair valueIndustry
- Altman Z-Score
- -12.71
- 0.23
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ACXP | S&P 500 | Difference | ACXP per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -20.0% | -3.0% | −17.0 pts | ||
| 3 months | -35.1% | -2.8% | −32.4 pts | ||
| Year to date | -61.4% | +11.5% | −72.9 pts | ||
| 1 year | -79.7% | +13.5% | −93.2 pts | ||
| 3 years | -98.6% | +77.7% | −176.3 pts | -76.1% | +21.1% |
| 5 years | -99.0% | +72.6% | −171.6 pts | -60.5% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M ACXP shares were sold short on Oct 30, 2026, up 7.5% from the previous report, or 3.62% of the shares available to trade. At recent volumes it would take 1.6 days to buy them back. Over the last 20 sessions, 41.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 97,568 | +7.5% | 60,021 | 1.6 |
| Oct 15, 2026 | 90,789 | -18.7% | 78,255 | 1.2 |
| Sep 30, 2026 | 111,697 | -10.0% | 109,661 | 1.0 |
| Sep 15, 2026 | 124,046 | +2.8% | 67,559 | 1.8 |
| Aug 31, 2026 | 120,691 | +28.2% | 224,680 | 1.0 |
| Aug 14, 2026 | 94,134 | -26.4% | 174,360 | 1.0 |
| Jul 31, 2026 | 127,922 | +25.1% | 71,458 | 1.8 |
| Jul 15, 2026 | 102,274 | -24.5% | 115,289 | 1.0 |
| Jun 30, 2026 | 135,522 | +25.0% | 78,761 | 1.7 |
| Jun 15, 2026 | 108,407 | +20.4% | 78,582 | 1.4 |
| May 29, 2026 | 90,033 | -37.1% | 105,286 | 1.0 |
| May 15, 2026 | 143,119 | +24.5% | 114,450 | 1.3 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?